This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
Lifordi Immunotherapeutics advances targeted glucocorticoid therapy for rheumatoid arthritis with breakthrough antibody-drug conjugate LFD-200, showing promising nonclinical results #Immunotherapy #Rheumatology
2025-10-31T20:48:06.920Z